Below is a structured extraction of all relevant and actionable financial information from the Jindal Worldwide Limited results filing dated 14th August 2025:


1. Auditor’s Note

  • The Statutory Auditors, Ravi Karia & Associates, have issued a Limited Review Report on both standalone and consolidated quarterly financial results for Q1 FY26 (quarter ended 30 June 2025).
  • The review was conducted under applicable Indian Accounting Standards (Ind AS 34) and SEBI Listing Regulations.
  • No qualifications, concerns, or issues were raised in the auditor’s report.
  • The auditor’s report states:
    “Nothing has come to our attention that causes us to believe that the accompanying statement... contains any material misstatement.”
  • The review included division auditors’ reports for certain divisions and subsidiaries.
  • The associate company Kashyap Tele-Medicines Ltd was divested on 20 May 2025 and hence excluded from associate results post that date.

Conclusion: Auditor’s note is clean with no qualifications or reservations.


2. Financial Performance

Key Financials (INR Lakhs except EPS)

ParticularsQ1 FY26 (30 Jun 2025)Q4 FY25 (31 Mar 2025)Q1 FY25 (30 Jun 2024)FY25 (Year ended 31 Mar 2025)
Standalone
Revenue from operations47,834.4355,582.8451,536.562,22,466.81
Other Income147.2745.33141.24267.86
Total Revenue47,981.7055,628.1751,677.802,22,734.67
Total Expenses46,141.6352,781.1549,350.582,12,784.99
Profit Before Tax (PBT)1,840.072,847.022,327.229,949.68
Tax Expense447.94779.68584.572,573.02
Net Profit1,392.132,067.341,742.657,376.66
EPS (Basic & Diluted)0.140.210.170.74
ParticularsQ1 FY26 (30 Jun 2025)Q4 FY25 (31 Mar 2025)Q1 FY25 (30 Jun 2024)FY25 (Year ended 31 Mar 2025)
Consolidated
Revenue from operations53,989.7460,553.3448,743.072,28,807.14
Other Income270.0145.11144.09270.65
Total Revenue54,259.7560,598.4548,887.162,29,077.79
Total Expenses51,984.1157,548.0546,441.362,18,714.14
Profit Before Tax (PBT)2,275.643,050.222,445.9110,363.64
Tax Expense531.77848.23639.612,777.25
Net Profit1,743.872,201.991,806.307,586.39
EPS (Basic & Diluted)0.170.220.180.76

Margins (approximate)

MetricQ1 FY26 (Standalone)Q1 FY26 (Consolidated)
Net Profit Margin (%)2.9%3.2%
EBITDA Proxy (PBT + Finance Cost + Depreciation)~4,107.31 (1,840.07 + 996.74 + 270.50)~4,303.09 (2,275.64 + 1,513.58 + 513.87)

3. Detailed Notes / Management Commentary

  • The results have been prepared in accordance with Indian Accounting Standards (Ind AS 34) and SEBI Listing Regulations.
  • The company operates primarily in the Textile business at standalone level, with only one reportable segment.
  • At consolidated level, the company reports two segments:
    • Textiles (main segment)
    • Electric Vehicles (minor segment, reported separately for information)
  • The company issued bonus shares in ratio 4:1 on 3 March 2025, increasing issued capital and restating EPS for prior periods accordingly.
  • The associate company Kashyap Tele-Medicines Ltd was divested on 20 May 2025 and is no longer part of the group post that date.
  • Figures for previous periods have been restated/regrouped for comparability.
  • The quarterly results for Q4 FY25 are balancing figures between audited full year and previously published quarterly results.
  • No changes in accounting policies or material adjustments were reported.
  • No specific commentary on margins, NPAs, slippages, or AUM (not applicable as company is in textiles and EV manufacturing).

4. Segment Information (Consolidated)

SegmentQ1 FY26 Revenue (INR Lakhs)Q4 FY25 Revenue (INR Lakhs)Q1 FY25 Revenue (INR Lakhs)FY25 Revenue (INR Lakhs)
Textiles53,989.7460,548.9548,734.032,28,776.52
Electric Vehicles-4.399.0430.62
Total53,989.7460,553.3448,743.072,28,807.14
SegmentQ1 FY26 Profit Before Interest & Tax (INR Lakhs)Q4 FY25Q1 FY25FY25
Textiles3,946.404,431.864,059.8617,006.98
Electric Vehicles(157.18)(166.50)(158.98)(697.46)
Total3,789.224,265.363,900.8816,309.52
Segment Assets (INR Lakhs)Q1 FY26Q4 FY25Q1 FY25FY25
Textiles1,69,024.541,74,929.591,72,746.711,74,929.59
Electric Vehicles4,680.024,679.154,391.724,679.15
Total1,73,704.561,79,608.741,77,138.431,79,608.74
Segment Liabilities (INR Lakhs)Q1 FY26Q4 FY25Q1 FY25FY25
Textiles92,582.841,00,225.921,03,049.911,00,225.92
Electric Vehicles364.20369.17374.90369.17
Total92,947.041,00,595.091,03,424.811,00,595.09

Note: Electric Vehicles segment is currently loss-making and small in scale relative to textiles.


5. Capex, Projects, Corporate Activity

  • No explicit mention of capital expenditure or ongoing/planned projects in the filing.
  • No reported writedowns, writebacks, impairments, or provisions.
  • Divestiture: Sold stake in associate Kashyap Tele-Medicines Ltd on 20 May 2025.
  • No acquisitions or mergers reported.
  • No restructuring or cost-cutting measures disclosed.

6. Standalone vs Consolidated

  • Both standalone and consolidated financial results are provided.
  • Consolidated results include parent and subsidiaries (Planet Spinning Mills Pvt Ltd, Goodcore Spintex Pvt Ltd, Jindal Mobilitric Pvt Ltd, IM Volt Pvt Ltd).
  • Associate Kashyap Tele-Medicines Ltd divested during the quarter.
  • Consolidated revenue and profit are higher than standalone, reflecting group operations.
  • Segment reporting is only available at consolidated level.

Summary for Investment Analysis Team

AspectKey Points
Auditor’s NoteClean limited review report with no qualifications or concerns.
Financial PerformanceQ1 FY26 standalone revenue at INR 47,834.43 Lakhs, down vs Q4 FY25 (55,582.84 Lakhs) and Q1 FY25 (51,536.56 Lakhs). Net profit at INR 1,392.13 Lakhs, down from Q4 FY25 but broadly stable YoY. Consolidated revenue and profit higher than standalone.
MarginsNet profit margin ~2.9% standalone, ~3.2% consolidated for Q1 FY26.
Segment InformationTextiles is main business; Electric Vehicles segment small and loss-making.
Corporate ActivityDivested associate Kashyap Tele-Medicines Ltd in May 2025.
Accounting ChangesBonus shares issued in March 2025 (4:1), EPS restated accordingly.
Capex/ProjectsNo disclosures on capex or new projects.
Risks/ConcernsElectric Vehicles segment continues to incur losses; no other material risks disclosed.

This structured summary provides a clear view of the company’s financial health, segment performance, and key corporate actions for Q1 FY26, suitable for investment decision-making.